Skin Ulcer Clinical Trial
Official title:
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Skin Ulcer
Verified date | November 2021 |
Source | The Foundation for Orthopaedics and Regenerative Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This trial will study the safety and efficacy of intravenous infusion and intralesional injection of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Skin Ulcer
Status | Suspended |
Enrollment | 20 |
Est. completion date | January 2026 |
Est. primary completion date | January 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Diagnosis of Skin Ulcer - Understanding and willingness to sign a written informed consent document Exclusion Criteria: - Active infection - Active cancer - Chronic multisystem organ failure - Pregnancy - Clinically significant Abnormalities on pre-treatment laboratory evaluation - Medical condition that would (based on the opinion of the investigator) compromise patient's safety. - Continued drug abuse - Pre-menopausal women not using contraception - Previous organ transplant - Hypersensitivity to sulfur |
Country | Name | City | State |
---|---|---|---|
Antigua and Barbuda | Medical Surgical Associates Center | St. John's |
Lead Sponsor | Collaborator |
---|---|
The Foundation for Orthopaedics and Regenerative Medicine |
Antigua and Barbuda,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Safety (adverse events) | Clinical monitoring of possible adverse events or complications | Four year follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01657318 -
Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers
|
||
Recruiting |
NCT04901325 -
Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
|
Phase 2 | |
Completed |
NCT02535481 -
Epidermal Grafting in Wound Healing
|
N/A | |
Completed |
NCT00006437 -
Pathophysiology of Chronic Wounds
|
N/A | |
Not yet recruiting |
NCT06369688 -
IDEAL SKIIN CARES Bundle to Prevent Pressure Injury
|
N/A | |
Active, not recruiting |
NCT02973893 -
Study of VF001-DP in Patients With Chronic Venous Leg Ulcers
|
Phase 2 | |
Recruiting |
NCT03957447 -
Treat Early and Broad: Thermotherapy of Buruli Ulcer Integrated Into WHO-recommended Wound Management in West Africa
|
||
Recruiting |
NCT02813213 -
Effectiveness Comparison of Skin Micro-grafts vs Meshed Split Thickness Skin Grafts
|
Phase 4 | |
Not yet recruiting |
NCT02309684 -
Bio-ConneKt Wound Dressing for Treatment of Chronic Leg Wounds: A Pilot Study
|
N/A | |
Recruiting |
NCT02280733 -
A Real World, Observational Registry of Chronic Wounds and Ulcers
|
||
Recruiting |
NCT04689243 -
Low Concentration ALA-PDT in Treatment of Skin Ulcer
|
N/A | |
Not yet recruiting |
NCT01770509 -
The Effect of the Cosmetic Cream NMBM on Leg Ulcers - a Pilot Study
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01219127 -
The Regeneration Effects of Derma-PACE Shockwave in Chronic Diabetic Ulcers
|
N/A | |
Completed |
NCT03445975 -
Washcloths Effectiveness in Preventing Pressure Ulcers
|
N/A | |
Terminated |
NCT00034788 -
A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX
|
Phase 3 | |
Recruiting |
NCT03823963 -
Study on Pressure Ulcers Prevention With Mepilex® Border Sacrum Dressing in Scheduled Cardiovascular Surgery
|
Phase 4 | |
Completed |
NCT02844166 -
Support Surfaces to Prevent Pressure Injuries
|
N/A | |
Recruiting |
NCT01932021 -
Treatment of Hypertensive Leg Ulcer by Adipose Tissue Grafting
|
N/A | |
Terminated |
NCT00691821 -
Negative Pressure Wound Therapy for the Treatment of Chronic Pressure Wounds
|
Phase 4 |